155 related articles for article (PubMed ID: 25560306)
1. Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.
Cremers RG; Galesloot TE; Aben KK; van Oort IM; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2015 Apr; 75(5):474-83. PubMed ID: 25560306
[TBL] [Abstract][Full Text] [Related]
2. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
3. Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.
Johanneson B; McDonnell SK; Karyadi DM; Quignon P; McIntosh L; Riska SM; FitzGerald LM; Johnson G; Deutsch K; Williams G; Tillmans LS; Stanford JL; Schaid DJ; Thibodeau SN; Ostrander EA
Hum Mol Genet; 2010 Oct; 19(19):3852-62. PubMed ID: 20631155
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
6. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
Ishak MB; Giri VN
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
[TBL] [Abstract][Full Text] [Related]
8. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
[TBL] [Abstract][Full Text] [Related]
9. Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?
Butoescu V; Ambroise J; Stainier A; Dekairelle AF; Gala JL; Tombal B
Prostate; 2014 Apr; 74(4):365-71. PubMed ID: 24265090
[TBL] [Abstract][Full Text] [Related]
10. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
Salinas CA; Koopmeiners JS; Kwon EM; FitzGerald L; Lin DW; Ostrander EA; Feng Z; Stanford JL
Prostate; 2009 Mar; 69(4):363-72. PubMed ID: 19058137
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Zheng SL; Mychaleckyj JC; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Chang BL; von Kap-Herr C; Carpten JD; Pettenati M; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Mutat Res; 2003 Jul; 528(1-2):45-53. PubMed ID: 12873722
[TBL] [Abstract][Full Text] [Related]
14. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J
Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652
[TBL] [Abstract][Full Text] [Related]
15. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
Chang B; Zheng SL; Isaacs SD; Wiley KE; Carpten JD; Hawkins GA; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Int J Cancer; 2001 Nov; 95(6):354-9. PubMed ID: 11668516
[TBL] [Abstract][Full Text] [Related]
16. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
Alberti C
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.
Na R; Liu F; Zhang P; Ye D; Xu C; Shao Q; Qi J; Wang X; Chen Z; Wang M; He D; Wang Z; Zhou F; Yuan J; Gao X; Wei Q; Yang J; Jiao Y; Ou-Yang J; Zhu Y; Wu Q; Chen H; Lu D; Shi R; Lin X; Jiang H; Wang Z; Jiang D; Sun J; Zheng SL; Ding Q; Mo Z; Sun Y; Xu J
Prostate; 2013 Nov; 73(15):1623-35. PubMed ID: 24038036
[TBL] [Abstract][Full Text] [Related]
18. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.
Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y
Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738
[TBL] [Abstract][Full Text] [Related]
19. Strategies for developing prediction models from genome-wide association studies.
Wu J; Pfeiffer RM; Gail MH
Genet Epidemiol; 2013 Dec; 37(8):768-77. PubMed ID: 24166696
[TBL] [Abstract][Full Text] [Related]
20. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
